Literature DB >> 8806634

Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR.

R L Kendall1, G Wang, K A Thomas.   

Abstract

A soluble form of the vascular endothelial growth factor (VEGF) receptor FLT-1 was identified in conditioned culture medium of human umbilical vein endothelial cells. The endogenous soluble FLT-1 (sFLT-1) receptor is chromatographically and immunologically similar to recombinant human sFLT-1 and binds [125I]VEGF with a comparable high affinity. Human sFLT-1 is shown to form a VEGF-stabilized complex with the extracellular domain of KDR in vitro, suggesting that not only full-length receptors are capable of forming ligand-induced heterodimeric complexes but also sFLT-1 can form a dominant negative complex with the mitogenically competent full-length KDR receptor.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8806634     DOI: 10.1006/bbrc.1996.1355

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  173 in total

Review 1.  Advances in gene therapy of liver cirrhosis: a review.

Authors:  W J Dai; H C Jiang
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

2.  Soluble VEGF receptor 1 promotes endothelial injury in children and adolescents with lupus nephritis.

Authors:  Monika Edelbauer; Sudhir Kshirsagar; Magdalena Riedl; Heiko Billing; Burkhard Tönshoff; Dieter Haffner; Jörg Dötsch; Gottfried Wechselberger; Lutz T Weber; Elisabeth Steichen-Gersdorf
Journal:  Pediatr Nephrol       Date:  2011-12-07       Impact factor: 3.714

Review 3.  Soluble flt-1 and the angiopoietins in the development and regulation of placental vasculature.

Authors:  D Stephen Charnock-Jones
Journal:  J Anat       Date:  2002-06       Impact factor: 2.610

4.  Inhibitory effect of antisense vascular endothelial growth factor 165 eukaryotic expression vector on proliferation of hepatocellular carcinoma cells.

Authors:  Song Gu; Chang-Jian Liu; Tong Qiao; Xue-Mei Sun; Lei-Lei Chen; Le Zhang
Journal:  World J Gastroenterol       Date:  2004-02-15       Impact factor: 5.742

5.  Coordinated DNA methylation and gene expression changes in smoker alveolar macrophages: specific effects on VEGF receptor 1 expression.

Authors:  Robert A Philibert; Rory A Sears; Linda S Powers; Emma Nash; Thomas Bair; Alicia K Gerke; Ihab Hassan; Christie P Thomas; Thomas J Gross; Martha M Monick
Journal:  J Leukoc Biol       Date:  2012-03-16       Impact factor: 4.962

6.  Angiogenic and immune signatures in plasma of young relatives at familial high-risk for psychosis and first-episode patients: A preliminary study.

Authors:  Paulo L Lizano; Matcheri S Keshavan; Neeraj Tandon; Ian T Mathew; Suraj Sarvode Mothi; Debra M Montrose; Jeffrey K Yao
Journal:  Schizophr Res       Date:  2015-12-11       Impact factor: 4.939

7.  Excess soluble vascular endothelial growth factor receptor-1 in amniotic fluid impairs lung growth in rats: linking preeclampsia with bronchopulmonary dysplasia.

Authors:  Jen-Ruey Tang; S Ananth Karumanchi; Gregory Seedorf; Neil Markham; Steven H Abman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-10-14       Impact factor: 5.464

8.  GM-CSF induces expression of soluble VEGF receptor-1 from human monocytes and inhibits angiogenesis in mice.

Authors:  Tim D Eubank; Ryan Roberts; Michelle Galloway; Yijie Wang; David E Cohn; Clay B Marsh
Journal:  Immunity       Date:  2004-12       Impact factor: 31.745

Review 9.  Hemangioblasts representing a functional endothelio-hematopoietic entity in ontogeny, postnatal life, and CML neovasculogenesis.

Authors:  Gregor Prindull
Journal:  Stem Cell Rev       Date:  2005       Impact factor: 5.739

10.  Cigarette smoke exposure and angiogenic factors in pregnancy and preeclampsia.

Authors:  Arun Jeyabalan; Robert W Powers; Allison R Durica; Gail F Harger; James M Roberts; Roberta B Ness
Journal:  Am J Hypertens       Date:  2008-06-19       Impact factor: 2.689

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.